162 related articles for article (PubMed ID: 38255096)
21. Incidence of unlicensed and off-label prescription in children.
Langerová P; Vrtal J; Urbánek K
Ital J Pediatr; 2014 Feb; 40():12. PubMed ID: 24495454
[TBL] [Abstract][Full Text] [Related]
22. Extent and nature of unlicensed and off-label medicine use in hospitalised children in Palestine.
Khdour MR; Hallak HO; Alayasa KS; AlShahed QN; Hawwa AF; McElnay JC
Int J Clin Pharm; 2011 Aug; 33(4):650-5. PubMed ID: 21567279
[TBL] [Abstract][Full Text] [Related]
23. Unlicensed and off-label prescription of respiratory drugs to children.
't Jong GW; Eland IA; Sturkenboom MC; van den Anker JN; Strickerf BH
Eur Respir J; 2004 Feb; 23(2):310-3. PubMed ID: 14979509
[TBL] [Abstract][Full Text] [Related]
24. Off-label use and harmful potential of drugs in a NICU in Brazil: A descriptive study.
de Souza AS; Dos Santos DB; Rey LC; Medeiros MG; Vieira MG; Coelho HLL
BMC Pediatr; 2016 Jan; 16():13. PubMed ID: 26795213
[TBL] [Abstract][Full Text] [Related]
25. Pattern and extent of off-label and unlicensed drug use in neonatal intensive care units in Iran.
Kouti L; Aletayeb M; Aletayeb SMH; Hardani AK; Eslami K
BMC Pediatr; 2019 Jan; 19(1):3. PubMed ID: 30609923
[TBL] [Abstract][Full Text] [Related]
26. [Off-label and unlicensed drug use: Results from a pilot study in a pediatric intensive care unit].
García-López I; Fuentes-Ríos JE; Manrique-Rodríguez S; M Fernández-Llamazares C
An Pediatr (Barc); 2017 Jan; 86(1):28-36. PubMed ID: 27151379
[TBL] [Abstract][Full Text] [Related]
27. Use of unlicensed and off-label medications in paediatric gastroenterology with a review of the commonly used formularies in the UK.
Dick A; Keady S; Mohamed F; Brayley S; Thomson M; Lloyd BW; Heuschkel R; Afzal NA
Aliment Pharmacol Ther; 2003 Feb; 17(4):571-5. PubMed ID: 12622766
[TBL] [Abstract][Full Text] [Related]
28. Pharmacoepidemiological evaluation of off label and unlicensed prescription in pediatric intensive care units at tertiary care hospitals of Peshawar, Pakistan.
Aamir M; Abid Shah M; Naheed Kauser T; Khan N; Mehmood I; Ali Khan J; Iqbal W
Pak J Pharm Sci; 2023 Jan; 36(1):81-87. PubMed ID: 36967500
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of unlicensed and off-label antiepileptic drugs prescribed to children: Brazilian Regulatory Agency versus FDA.
Borges AP; Campos MS; Pereira LR
Int J Clin Pharm; 2013 Jun; 35(3):425-31. PubMed ID: 23430533
[TBL] [Abstract][Full Text] [Related]
30. [Off-label use of psychotropic medications in pediatric wards: a prospective study].
Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689
[TBL] [Abstract][Full Text] [Related]
31. Off-label and unlicensed drug use in a Spanish Neonatal Intensive Care Unit.
Arocas Casañ V; Cabezuelo Escribano B; Garrido-Corro B; De la Cruz Murie P; Blázquez Álvarez MJ; De la Rubia Nieto MªA
Farm Hosp; 2017 May; 41(3):371-381. PubMed ID: 28478751
[TBL] [Abstract][Full Text] [Related]
32. A survey of the use of off-label and unlicensed drugs in a Dutch children's hospital.
't Jong GW; Vulto AG; de Hoog M; Schimmel KJ; Tibboel D; van den Anker JN
Pediatrics; 2001 Nov; 108(5):1089-93. PubMed ID: 11694685
[TBL] [Abstract][Full Text] [Related]
33. Unlicensed and off-label drug use in children: implications for safety.
Choonara I; Conroy S
Drug Saf; 2002; 25(1):1-5. PubMed ID: 11820908
[TBL] [Abstract][Full Text] [Related]
34. Unlicensed and off-label use of drugs in pediatric surgical units at tertiary care hospitals of Pakistan.
Aamir M; Khan JA; Shakeel F; Asim SM
Int J Clin Pharm; 2017 Aug; 39(4):860-866. PubMed ID: 28597174
[TBL] [Abstract][Full Text] [Related]
35. Off label and unlicensed drugs use in paediatric cardiology.
Bajcetic M; Jelisavcic M; Mitrovic J; Divac N; Simeunovic S; Samardzic R; Gorodischer R
Eur J Clin Pharmacol; 2005 Nov; 61(10):775-9. PubMed ID: 16151762
[TBL] [Abstract][Full Text] [Related]
36. Unlicensed and off-label use of medicines at a neonatology clinic in Italy.
Dell'Aera M; Gasbarro AR; Padovano M; Laforgia N; Capodiferro D; Solarino B; Quaranta R; Dell'Erba AS
Pharm World Sci; 2007 Aug; 29(4):361-7. PubMed ID: 17351821
[TBL] [Abstract][Full Text] [Related]
37. Relationship between adverse drug reactions and unlicensed/off-label drug use in hospitalized children (EREMI): A study protocol.
Nguyen KA; Mimouni Y; Jaberi E; Paret N; Boussaha I; Vial T; Jacqz-Aigrain E; Alberti C; Guittard L; Remontet L; Roche L; Bossard N; Kassai B
Therapie; 2021; 76(6):675-685. PubMed ID: 33593598
[TBL] [Abstract][Full Text] [Related]
38. Unlicensed and Off-Label Medication Use in Pediatric and Neonatal Intensive Care Units: No Change Over a Decade.
Nir-Neuman H; Abu-Kishk I; Toledano M; Heyman E; Ziv-Baran T; Berkovitch M
Adv Ther; 2018 Jul; 35(7):1122-1132. PubMed ID: 29949042
[TBL] [Abstract][Full Text] [Related]
39. Unlicensed and off-label drug use in paediatrics in a mother-child tertiary care hospital.
Corny J; Bailey B; Lebel D; Bussières JF
Paediatr Child Health; 2016 Mar; 21(2):83-7. PubMed ID: 27095883
[TBL] [Abstract][Full Text] [Related]
40. Off-label and unlicensed use of medicinal products in the neonatal setting in the Slovak Republic.
Schweigertova J; Durisova A; Dolnikova D; Ondriasova E; Balazova M; Slezakova V; Kuzelova M
Pediatr Int; 2016 Feb; 58(2):126-31. PubMed ID: 26256925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
